BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30321986)

  • 1. Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.
    Wanek J; Gaisberger M; Beyreis M; Mayr C; Helm K; Primavesi F; Jäger T; Di Fazio P; Jakab M; Wagner A; Neureiter D; Kiesslich T
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
    Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
    Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor LMK-235-mediated HO-1 expression induces apoptosis in multiple myeloma cells via the JNK/AP-1 signaling pathway.
    Li X; Guo Y; Kuang X; Zhao L; Li H; Cheng B; Wang W; Zhang Z; Liu P; Wang J
    Life Sci; 2019 Apr; 223():146-157. PubMed ID: 30876940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
    Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY
    J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells.
    Arvidsson Y; Johanson V; Pfragner R; Wängberg B; Nilsson O
    Neuroendocrinology; 2016; 103(5):578-91. PubMed ID: 26505883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of BCLAF1 on HDAC inhibitor LMK-235-mediated apoptosis of diffuse large B cell lymphoma cells and its mechanism.
    Li X; He Z; Cheng B; Fang Q; Ma D; Lu T; Wei D; Kuang X; Tang S; Xiong J; Wang J
    Cancer Biol Ther; 2018; 19(9):825-834. PubMed ID: 29969367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatment.
    Bauden M; Tassidis H; Ansari D
    Toxicol Lett; 2015 Jul; 236(1):8-15. PubMed ID: 25917448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.
    Li A; Liu Z; Li M; Zhou S; Xu Y; Xiao Y; Yang W
    Oncotarget; 2016 Jun; 7(25):37966-37978. PubMed ID: 27177225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs.
    Wang Y; Wallach J; Duane S; Wang Y; Wu J; Wang J; Adejare A; Ma H
    Drug Des Devel Ther; 2017; 11():1369-1382. PubMed ID: 28496307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.
    Lenoir O; Flosseau K; Ma FX; Blondeau B; Mai A; Bassel-Duby R; Ravassard P; Olson EN; Haumaitre C; Scharfmann R
    Diabetes; 2011 Nov; 60(11):2861-71. PubMed ID: 21953612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
    Zhao B; He T
    Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of HO-1 promotes resistance of B-cell acute lymphocytic leukemia cells to HDAC4/5 inhibitor LMK-235 via the Smad7 pathway.
    Guo Y; Fang Q; Ma D; Yu K; Cheng B; Tang S; Lu T; Wang W; Wang J
    Life Sci; 2018 Aug; 207():386-394. PubMed ID: 29886060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells.
    Colarossi L; Memeo L; Colarossi C; Aiello E; Iuppa A; Espina V; Liotta L; Mueller C
    Proteomics Clin Appl; 2014 Dec; 8(11-12):924-31. PubMed ID: 25091122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
    Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
    Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.
    Klieser E; Urbas R; Swierczynski S; Stättner S; Primavesi F; Jäger T; Mayr C; Kiesslich T; Fazio PD; Helm K; Neureiter D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.
    Roccaro AM; Sacco A; Jia X; Azab AK; Maiso P; Ngo HT; Azab F; Runnels J; Quang P; Ghobrial IM
    Blood; 2010 Sep; 116(9):1506-14. PubMed ID: 20519629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
    Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
    Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells.
    Usami M; Kikuchi S; Takada K; Ono M; Sugama Y; Arihara Y; Hayasaka N; Nakamura H; Ikeda Y; Hirakawa M; Yoshida M; Miyanishi K; Kobune M; Kato J
    Pancreas; 2020 Jan; 49(1):135-142. PubMed ID: 31856089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.